Fryk, E., Rodrigues Silva, V. R., Bauzá-Thorbrügge, M., Schmelz, M., Gan, L., Strindberg, L., & Jansson, P. (2023). Feasibility of high-dose tadalafil and effects on insulin resistance in well-controlled patients with type 2 diabetes (MAKROTAD): A single-centre, double-blind, randomised, placebo-controlled, cross-over phase 2 trial. EClinicalMedicine, 59, . https://doi.org/10.1016/j.eclinm.2023.101985
Chicago-Zitierstil (17. Ausg.)Fryk, Emanuel, Vagner Ramon Rodrigues Silva, Marco Bauzá-Thorbrügge, Martin Schmelz, Li-Ming Gan, Lena Strindberg, und Per-Anders Jansson. "Feasibility of High-dose Tadalafil and Effects on Insulin Resistance in Well-controlled Patients with Type 2 Diabetes (MAKROTAD): A Single-centre, Double-blind, Randomised, Placebo-controlled, Cross-over Phase 2 Trial." EClinicalMedicine 59 (2023). https://doi.org/10.1016/j.eclinm.2023.101985.
MLA-Zitierstil (9. Ausg.)Fryk, Emanuel, et al. "Feasibility of High-dose Tadalafil and Effects on Insulin Resistance in Well-controlled Patients with Type 2 Diabetes (MAKROTAD): A Single-centre, Double-blind, Randomised, Placebo-controlled, Cross-over Phase 2 Trial." EClinicalMedicine, vol. 59, 2023, https://doi.org/10.1016/j.eclinm.2023.101985.